Immunocore Holdings plc
IMCR
$33.30
$1.434.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.35% | 11.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.35% | 11.69% | |||
| Cost of Revenue | 8,329.36% | 100.56% | |||
| Gross Profit | -70.00% | -59.77% | |||
| SG&A Expenses | 6.45% | -5.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.74% | 14.09% | |||
| Operating Income | -311.37% | -158.10% | |||
| Income Before Tax | -259.34% | 124.51% | |||
| Income Tax Expenses | -42.88% | 201.05% | |||
| Earnings from Continuing Operations | -305.06% | 121.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -305.06% | 121.13% | |||
| EBIT | -311.37% | -158.10% | |||
| EBITDA | -410.32% | -1,075.32% | |||
| EPS Basic | -304.19% | 121.12% | |||
| Normalized Basic EPS | -1,664.94% | 102.94% | |||
| EPS Diluted | -304.80% | 121.05% | |||
| Normalized Diluted EPS | -1,728.38% | 102.83% | |||
| Average Basic Shares Outstanding | 0.41% | 0.08% | |||
| Average Diluted Shares Outstanding | -3.19% | 3.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||